NextCure, Inc.
NXTC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001661059
In the last 90 days, NextCure, Inc. insiders filed 2 open-market purchases and 1 sale; 30 institutions reported holding it in 13F filings for Q2 2026, worth $2.78M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in NextCure, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 30
- +4 vs. Q1 2026
- Shares held
- 1.74M
- −434.3K (−20.0%) vs. Q1 2026
- Total value
- $2.78M
- −$20.2M (−87.9%) vs. Q1 2026
- New holders
- 11
- 8 more added
- Sold out
- 7
- 5 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NXTC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 30 | $2.78M |
| Q1 2026 | 26 | $23.0M |
| Q4 2025 | 24 | $26.9M |
| Q3 2025 | 17 | $5.03M |
| Q2 2025 | 30 | $5.65M |
| Q1 2025 | 38 | $7.38M |
| Q4 2024 | 46 | $13.1M |
| Q3 2024 | 44 | $21.7M |
| Q2 2024 | 49 | $25.5M |
| Q1 2024 | 47 | $36.0M |
| Q4 2023 | 43 | $15.3M |
| Q3 2023 | 41 | $16.6M |
| Q2 2023 | 43 | $24.0M |
| Q1 2023 | 44 | $19.6M |
| Q4 2022 | 45 | $18.9M |
| Q3 2022 | 52 | $41.8M |
| Q2 2022 | 51 | $67.9M |
| Q1 2022 | 59 | $64.3M |
| Q4 2021 | 71 | $86.2M |
| Q3 2021 | 71 | $99.5M |
| Q2 2021 | 78 | $124.2M |
| Q1 2021 | 92 | $179.8M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding NextCure, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ikarian Capital, LLC | 288,303 | $461.3K | 0.08% | +50,000+21.0% | Added |
| Adage Capital Partners GP, L.L.C. | 277,202 | $443.5K | 0.00% | +277,202 | New |
| Sofinnova Investments, Inc. | 222,654 | $356.2K | 0.02% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 171,202 | $273.9K | 0.00% | +110,668+182.8% | Added |
| Vanguard Capital Management LLC | 156,842 | $250.9K | 0.00% | −3,631−2.3% | Reduced |
| Millennium Management LLC | 88,112 | $141.0K | 0.00% | +88,112 | New |
| Boothbay Fund Management, LLC | 84,687 | $135.5K | 0.00% | +15,070+21.6% | Added |
| Squadron Capital Management LLC | 64,464 | $103.1K | 0.04% | −200,536−75.7% | Reduced |
| Verdad Advisers, LP | 60,451 | $96.7K | 0.09% | +17,496+40.7% | Added |
| Pfizer Inc | 44,347 | $73.0K | 0.04% | −109,007−71.1% | Reduced |
| Affinity Asset Advisors, LLC | 41,960 | $67.1K | 0.00% | −199,866−82.6% | Reduced |
| BlackRock, Inc. | 37,348 | $59.8K | 0.00% | +9,555+34.4% | Added |
| HRT Financial LP | 36,450 | $58.0K | 0.00% | +36,450 | New |
| Jane Street Group, LLC | 32,725 | $52.4K | 0.00% | +32,725 | New |
| Geode Capital Management, LLC | 29,905 | $47.9K | 0.00% | −1,187−3.8% | Reduced |
| Cardiff Park Advisors, LLC | 21,833 | $34.9K | 0.00% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 18,982 | $30.0K | 0.00% | 00.0% | Unchanged |
| Vanguard Fiduciary Trust Co | 16,134 | $25.8K | 0.00% | +119+0.7% | Added |
| Nomura Asset Management International Inc. | 12,500 | $20.0K | 0.00% | +12,500 | New |
| Virtu Financial LLC | 10,991 | $18.0K | 0.00% | +10,991 | New |
| Diadema Partners LP | 7,742 | $12.4K | 0.00% | +7,742 | New |
| Barclays PLC | 5,726 | $9.16K | 0.00% | +100+1.8% | Added |
| Persistent Asset Partners Ltd | 1,981 | $3.17K | 0.00% | +1,981 | New |
| Tower Research Capital LLC (TRC) | 1,738 | $2.78K | 0.00% | +1,738 | New |
| UBS Group AG | 594 | $951 | 0.00% | +256+75.7% | Added |
| Northwestern Mutual Wealth Management Co | 83 | $133 | 0.00% | +83 | New |
| JPMorgan Chase & Co | 61 | $107 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 66 | $106 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 32 | $51 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 20 | $32 | 0.00% | +20 | New |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −176,057−100.0% | Sold out |
| Opaleye Management Inc. | 0 | $0 | 0.00% | −141,181−100.0% | Sold out |
| AWM Investment Company, Inc. | 0 | $0 | 0.00% | −117,371−100.0% | Sold out |
| Exome Asset Management LLC | 0 | $0 | 0.00% | −115,500−100.0% | Sold out |
| Woodline Partners LP | 0 | $0 | 0.00% | −27,498−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −15,292−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −1−100.0% | Sold out |